Small-cap Health Care company Canopy Growth has logged a 1.1% change today on a trading volume of 1,775,509. The average volume for the stock is 7,433,390.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Based in Smiths Falls, Canada the company has 3,151 full time employees and a market cap of $905,705,600.
The company is now trading -7.57% away from its average analyst target price of $1.98 per share. The 5 analysts following the stock have set target prices ranging from $1.0 to $3.32, and on average give Canopy Growth a rating of underperform.
Over the last year, CGC shares have gone down by -7726.0%, which represents a difference of -6355.0% when compared to the S&P 500. The stock's 52 week high is $8.64 per share and its 52 week low is $1.81. With its gross margins declining an average -67.2% over the last four years, Canopy Growth may not have a strong enough business to reverse this trend.
|Date Reported||Revenue ($ k)||Cost of Revenue ($ k)||Gross Margins (%)||YoY Growth (%)|